Article info
PDFClinical science
Original article
Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity
- Correspondence to Dr Brian P Marr, Ophthalmic Oncology Service, Memorial Sloan-Kettering Cancer Center, 70 East 66th Street, New York, NY 10065, USA; marrb{at}mskcc.org
Citation
Periocular carboplatin for retinoblastoma: long-term report (12 years) on efficacy and toxicity
Publication history
- Accepted January 18, 2012
- First published February 10, 2012.
Online issue publication
May 15, 2012
Article Versions
- Previous version (10 February 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2012, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.